Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

Trends, Determinants, and Impact on Survival of Post-Lung Transplant Weight Changes: A Single-center Longitudinal Retrospective Study.

Jomphe V, Nguyen C, Durette G, Chagnon M, Nasir B, Poirier C, Ferraro P, Lands LC, Mailhot G.

Transplantation. 2019 Dec;103(12):2614-2623. doi: 10.1097/TP.0000000000002696.

PMID:
31765365
2.

Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele.

Middleton PG, Mall MA, Dřevínek P, Lands LC, McKone EF, Polineni D, Ramsey BW, Taylor-Cousar JL, Tullis E, Vermeulen F, Marigowda G, McKee CM, Moskowitz SM, Nair N, Savage J, Simard C, Tian S, Waltz D, Xuan F, Rowe SM, Jain R; VX17-445-102 Study Group.

N Engl J Med. 2019 Nov 7;381(19):1809-1819. doi: 10.1056/NEJMoa1908639. Epub 2019 Oct 31.

PMID:
31697873
3.

Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis.

Lands LC, Stanojevic S.

Cochrane Database Syst Rev. 2019 Sep 9;9:CD001505. doi: 10.1002/14651858.CD001505.pub5.

PMID:
31499593
4.

Cardiopulmonary Exercise Testing Provides Additional Prognostic Information in Cystic Fibrosis.

Hebestreit H, Hulzebos EHJ, Schneiderman JE, Karila C, Boas SR, Kriemler S, Dwyer T, Sahlberg M, Urquhart DS, Lands LC, Ratjen F, Takken T, Varanistkaya L, Rücker V, Hebestreit A, Usemann J, Radtke T; Prognostic Value of CPET in CF Study Group.

Am J Respir Crit Care Med. 2019 Apr 15;199(8):987-995. doi: 10.1164/rccm.201806-1110OC.

PMID:
30321487
5.

Nutritional Requirements of Lung Transplant Recipients: Challenges and Considerations.

Jomphe V, Lands LC, Mailhot G.

Nutrients. 2018 Jun 19;10(6). pii: E790. doi: 10.3390/nu10060790. Review.

6.

Effects of a partially supervised conditioning programme in cystic fibrosis: an international multi-centre randomised controlled trial (ACTIVATE-CF): study protocol.

Hebestreit H, Lands LC, Alarie N, Schaeff J, Karila C, Orenstein DM, Urquhart DS, Hulzebos EHJ, Stein L, Schindler C, Kriemler S, Radtke T; ACTIVATE-CF Study Working Group.

BMC Pulm Med. 2018 Feb 8;18(1):31. doi: 10.1186/s12890-018-0596-6.

7.

Methacholine challenge test: Comparison of tidal breathing and dosimeter methods in children.

Mazi A, Lands LC, Zielinski D.

Pediatr Pulmonol. 2018 Feb;53(2):174-180. doi: 10.1002/ppul.23890. Epub 2017 Nov 27.

PMID:
29178471
8.

CFTR Genotype and Maximal Exercise Capacity in Cystic Fibrosis: A Cross-sectional Study.

Radtke T, Hebestreit H, Gallati S, Schneiderman JE, Braun J, Stevens D, Hulzebos EH, Takken T, Boas SR, Urquhart DS, Lands LC, Tejero S, Sovtic A, Dwyer T, Petrovic M, Harris RA, Karila C, Savi D, Usemann J, Mei-Zahav M, Hatziagorou E, Ratjen F, Kriemler S; CFTR-Exercise study group.

Ann Am Thorac Soc. 2018 Feb;15(2):209-216. doi: 10.1513/AnnalsATS.201707-570OC. Epub 2017 Nov 15.

9.

Adverse events following live-attenuated intranasal influenza vaccination of children with cystic fibrosis: Results from two influenza seasons.

Boikos C, Joseph L, Scheifele D, Lands LC, De Serres G, Papenburg J, Winters N, Chilvers M, Quach C.

Vaccine. 2017 Sep 5;35(37):5019-5026. doi: 10.1016/j.vaccine.2017.07.068. Epub 2017 Jul 31.

PMID:
28774563
10.

Pulmonary Pseudomonas aeruginosa infection induces autophagy and proteasome proteolytic pathways in skeletal muscles: effects of a pressurized whey protein-based diet in mice.

Kishta OA, Guo Y, Mofarrahi M, Stana F, Lands LC, Hussain SNA.

Food Nutr Res. 2017 Jun 1;61(1):1325309. doi: 10.1080/16546628.2017.1325309. eCollection 2017.

11.

Dyspnea in Children: What is driving it and how to approach it.

Lands LC.

Paediatr Respir Rev. 2017 Sep;24:29-31. doi: 10.1016/j.prrv.2017.03.013. Epub 2017 Mar 31. Review.

PMID:
28433261
12.

Urine biomarkers of acute kidney injury in noncritically ill, hospitalized children treated with chemotherapy.

Sterling M, Al-Ismaili Z, McMahon KR, Piccioni M, Pizzi M, Mottes T, Lands LC, Abish S, Fleming AJ, Bennett MR, Palijan A, Devarajan P, Goldstein SL, O'Brien MM, Zappitelli M.

Pediatr Blood Cancer. 2017 Oct;64(10). doi: 10.1002/pbc.26538. Epub 2017 Apr 18.

PMID:
28417544
13.

Viral interference and the live-attenuated intranasal influenza vaccine: Results from a pediatric cohort with cystic fibrosis.

Boikos C, Papenburg J, Martineau C, Joseph L, Scheifele D, Chilvers M, Lands LC, De Serres G, Quach C.

Hum Vaccin Immunother. 2017 Jun 3;13(6):1-7. doi: 10.1080/21645515.2017.1287641. Epub 2017 Mar 8.

14.

Inhaled dry powder mannitol in children with cystic fibrosis: A randomised efficacy and safety trial.

De Boeck K, Haarman E, Hull J, Lands LC, Moeller A, Munck A, Riethmüller J, Tiddens H, Volpi S, Leadbetter J, Charlton B, Malfroot A; DPM-CF-204 Study Group.

J Cyst Fibros. 2017 May;16(3):380-387. doi: 10.1016/j.jcf.2017.02.003. Epub 2017 Mar 1.

15.

Impaired rib bone mass and quality in end-stage cystic fibrosis patients.

Mailhot G, Dion N, Farlay D, Rizzo S, Bureau NJ, Jomphe V, Sankhe S, Boivin G, Lands LC, Ferraro P, Ste-Marie LG.

Bone. 2017 May;98:9-17. doi: 10.1016/j.bone.2017.02.007. Epub 2017 Feb 22.

PMID:
28254466
16.

C-Reactive Protein in Stable Cystic Fibrosis: An Additional Indicator of Clinical Disease Activity and Risk of Future Pulmonary Exacerbations.

Matouk E, Nguyen D, Benedetti A, Bernier J, Gruber J, Landry J, Rousseau S, Ahlgren HG, Lands LC, Wojewodka G, Radzioch D.

J Pulm Respir Med. 2016 Oct 14;6(5):1000375. doi: 10.4172/2161-105X.1000375.

17.

Secondary Pulmonary Hypertension: Who to consider, how to confirm and when to follow-up.

Fitzgerald DA, Eber E, Lands LC.

Paediatr Respir Rev. 2017 Jun;23:1-2. doi: 10.1016/j.prrv.2016.10.008. Epub 2016 Oct 31. No abstract available.

PMID:
27986505
18.

Pathophysiology, screening and diagnosis of pulmonary hypertension in infants with bronchopulmonary dysplasia - A review of the literature.

Altit G, Dancea A, Renaud C, Perreault T, Lands LC, Sant'Anna G.

Paediatr Respir Rev. 2017 Jun;23:16-26. doi: 10.1016/j.prrv.2016.11.002. Epub 2016 Nov 9. Review.

PMID:
27986502
19.

Influenza Virus Detection Following Administration of Live-Attenuated Intranasal Influenza Vaccine in Children With Cystic Fibrosis and Their Healthy Siblings.

Boikos C, Joseph L, Martineau C, Papenburg J, Scheifele D, Lands LC, De Serres G, Chilvers M, Quach C.

Open Forum Infect Dis. 2016 Aug 30;3(4):ofw187. eCollection 2016 Oct.

20.

Serum cystatin C for acute kidney injury evaluation in children treated with aminoglycosides.

Lau L, Al-Ismaili Z, Harel-Sterling M, Pizzi M, Caldwell JS, Piccioni M, Lands LC, Mottes T, Devarajan P, Goldstein SL, Bennett MR, Zappitelli M.

Pediatr Nephrol. 2017 Jan;32(1):163-171. Epub 2016 Oct 14.

21.

Authors' Reply.

Hebestreit H, Arets HG, Aurora P, Boas S, Cerny F, Hulzebos EH, Karila C, Lands LC, Lowman JD, Swisher A, Urquhart DS; Cystic Fibrosis Exercise Working Group.

Respiration. 2016;92(1):63-4. doi: 10.1159/000447654. Epub 2016 Jul 1. No abstract available.

22.

Perioperative Steroids in Pediatric Cardiopulmonary Bypass: We Still Do Not Have All the Answers.

Withington DE, Fontela PS, Harrington KP, Lands LC.

Pediatr Crit Care Med. 2016 May;17(5):475. doi: 10.1097/PCC.0000000000000679. No abstract available.

PMID:
27144701
23.

The benefits of newborn screening for cystic fibrosis: The Canadian experience.

Mak DY, Sykes J, Stephenson AL, Lands LC.

J Cyst Fibros. 2016 May;15(3):302-8. doi: 10.1016/j.jcf.2016.04.001. Epub 2016 Apr 21.

24.

Could relative abundance of airway lipoxins be the clue to restore corticosteroid sensitivity in severe asthma?

Dauletbaev N, Lands LC.

J Allergy Clin Immunol. 2016 Jun;137(6):1807-1808. doi: 10.1016/j.jaci.2016.02.012. Epub 2016 Apr 12. No abstract available.

PMID:
27084402
25.

Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis.

Lands LC, Stanojevic S.

Cochrane Database Syst Rev. 2016 Apr 7;4:CD001505. doi: 10.1002/14651858.CD001505.pub4. Review. Update in: Cochrane Database Syst Rev. 2019 Sep 09;9:CD001505.

PMID:
27055154
26.

Whole Body Plethysmography: Practical Considerations.

Zysman-Colman Z, Lands LC.

Paediatr Respir Rev. 2016 Jun;19:39-41. doi: 10.1016/j.prrv.2015.11.008. Epub 2015 Dec 8. Review.

PMID:
26796416
27.

Airway hyperreactivity is frequent in non-asthmatic children with sickle cell disease.

Shilo NR, Alawadi A, Allard-Coutu A, Robitaille N, Pastore Y, Bérubé D, Jacob SV, Abish S, Dauletbaev N, Lands LC.

Pediatr Pulmonol. 2016 Sep;51(9):950-7. doi: 10.1002/ppul.23374. Epub 2015 Dec 30.

PMID:
26716600
28.

Rhinovirus Load Is High despite Preserved Interferon-β Response in Cystic Fibrosis Bronchial Epithelial Cells.

Dauletbaev N, Das M, Cammisano M, Chen H, Singh S, Kooi C, Leigh R, Beaudoin T, Rousseau S, Lands LC.

PLoS One. 2015 Nov 23;10(11):e0143129. doi: 10.1371/journal.pone.0143129. eCollection 2015.

29.

Statement on Exercise Testing in Cystic Fibrosis.

Hebestreit H, Arets HG, Aurora P, Boas S, Cerny F, Hulzebos EH, Karila C, Lands LC, Lowman JD, Swisher A, Urquhart DS; European Cystic Fibrosis Exercise Working Group.

Respiration. 2015;90(4):332-51. doi: 10.1159/000439057. Epub 2015 Sep 9.

30.

Stimulation of the RIG-I/MAVS Pathway by Polyinosinic:Polycytidylic Acid Upregulates IFN-β in Airway Epithelial Cells with Minimal Costimulation of IL-8.

Dauletbaev N, Cammisano M, Herscovitch K, Lands LC.

J Immunol. 2015 Sep 15;195(6):2829-41. doi: 10.4049/jimmunol.1400840. Epub 2015 Aug 17.

31.

Down-regulation of IL-8 by high-dose vitamin D is specific to hyperinflammatory macrophages and involves mechanisms beyond up-regulation of DUSP1.

Dauletbaev N, Herscovitch K, Das M, Chen H, Bernier J, Matouk E, Bérubé J, Rousseau S, Lands LC.

Br J Pharmacol. 2015 Oct;172(19):4757-71. doi: 10.1111/bph.13249.

32.

Lund-Mackay and modified Lund-Mackay score for sinus surgery in children with cystic fibrosis.

Do BA, Lands LC, Mascarella MA, Fanous A, Saint-Martin C, Manoukian JJ, Nguyen LH.

Int J Pediatr Otorhinolaryngol. 2015 Aug;79(8):1341-5. doi: 10.1016/j.ijporl.2015.06.007. Epub 2015 Jun 11.

PMID:
26115934
33.

Clinical outcomes associated with Staphylococcus aureus and Pseudomonas aeruginosa airway infections in adult cystic fibrosis patients.

Ahlgren HG, Benedetti A, Landry JS, Bernier J, Matouk E, Radzioch D, Lands LC, Rousseau S, Nguyen D.

BMC Pulm Med. 2015 Jun 21;15:67. doi: 10.1186/s12890-015-0062-7.

34.

High Hydrostatic Pressure Pretreatment of Whey Protein Isolates Improves Their Digestibility and Antioxidant Capacity.

Iskandar MM, Lands LC, Sabally K, Azadi B, Meehan B, Mawji N, Skinner CD, Kubow S.

Foods. 2015 May 28;4(2):184-207. doi: 10.3390/foods4020184.

35.

Clinical Potential of Hyperbaric Pressure-Treated Whey Protein.

Piccolomini AF, Kubow S, Lands LC.

Healthcare (Basel). 2015 Jun 19;3(2):452-65. doi: 10.3390/healthcare3020452. Review.

36.

Can I play?

LeBlanc CM, Lands LC.

Pediatr Ann. 2014 Dec;43(12):e316-24. doi: 10.3928/00904481-20141124-11.

PMID:
25486040
37.

Safety of live-attenuated influenza vaccination in cystic fibrosis.

Boikos C, De Serres G, Lands LC, Boucher FD, Tapiéro B, Daigneault P, Quach C.

Pediatrics. 2014 Oct;134(4):e983-91. doi: 10.1542/peds.2014-0887. Epub 2014 Sep 15. Erratum in: Pediatrics. 2016 Oct;138(4):null.

PMID:
25225145
38.

A comparison of three dose timings of methylprednisolone in infant cardiopulmonary bypass.

Withington DE, Fontela PS, Harrington KP, Tchervenkov C, Lands LC.

Springerplus. 2014 Aug 29;3:484. doi: 10.1186/2193-1801-3-484. eCollection 2014.

39.

Effect of lowering methacholine challenge test cutoff in children.

Mazi A, Lands LC.

Ann Allergy Asthma Immunol. 2014 Oct;113(4):393-7. doi: 10.1016/j.anai.2014.06.024. Epub 2014 Aug 1.

PMID:
25091717
40.

Effect of the F508del genotype on outcomes of endoscopic sinus surgery in children with cystic fibrosis.

Do BA, Lands LC, Saint-Martin C, Mascarella MA, Manoukian JJ, Daniel SJ, Nguyen LH.

Int J Pediatr Otorhinolaryngol. 2014 Jul;78(7):1133-7. doi: 10.1016/j.ijporl.2014.04.030. Epub 2014 Apr 26.

PMID:
24791677
41.

Candidate markers associated with the probability of future pulmonary exacerbations in cystic fibrosis patients.

Wojewodka G, De Sanctis JB, Bernier J, Bérubé J, Ahlgren HG, Gruber J, Landry J, Lands LC, Nguyen D, Rousseau S, Benedetti A, Matouk E, Radzioch D.

PLoS One. 2014 Feb 12;9(2):e88567. doi: 10.1371/journal.pone.0088567. eCollection 2014.

42.

A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis.

Konstan MW, Döring G, Heltshe SL, Lands LC, Hilliard KA, Koker P, Bhattacharya S, Staab A, Hamilton A; Investigators and Coordinators of BI Trial 543.45.

J Cyst Fibros. 2014 Mar;13(2):148-55. doi: 10.1016/j.jcf.2013.12.009. Epub 2014 Jan 17.

43.

Vitamin D as an anti-microbial and anti-inflammatory therapy for Cystic Fibrosis.

Herscovitch K, Dauletbaev N, Lands LC.

Paediatr Respir Rev. 2014 Jun;15(2):154-62. doi: 10.1016/j.prrv.2013.11.002. Epub 2013 Nov 14. Review.

PMID:
24332502
44.

Chorioamnionitis and bronchopulmonary dysplasia in evolution.

Lands LC.

Paediatr Respir Rev. 2014 Mar;15(1):47-8. doi: 10.1016/j.prrv.2013.09.003. Epub 2013 Nov 5. No abstract available.

PMID:
24210583
45.

Longitudinal relationship between physical activity and lung health in patients with cystic fibrosis.

Schneiderman JE, Wilkes DL, Atenafu EG, Nguyen T, Wells GD, Alarie N, Tullis E, Lands LC, Coates AL, Corey M, Ratjen F.

Eur Respir J. 2014 Mar;43(3):817-23. doi: 10.1183/09031936.00055513. Epub 2013 Oct 31.

46.

Pulmonary exacerbations in CF patients with early lung disease.

Anstead M, Saiman L, Mayer-Hamblett N, Lands LC, Kloster M, Goss CH, Rose L, Burns JL, Marshall B, Ratjen F.

J Cyst Fibros. 2014 Jan;13(1):74-9. doi: 10.1016/j.jcf.2013.07.006. Epub 2013 Sep 10.

47.

Impact of acute antibiotic therapy on the pulmonary exacerbation endpoint in cystic fibrosis clinical trials.

Mayer-Hamblett N, Saiman L, Lands LC, Anstead M, Rosenfeld M, Kloster M, Fisher L, Ratjen F.

Contemp Clin Trials. 2013 Sep;36(1):99-105. doi: 10.1016/j.cct.2013.06.004. Epub 2013 Jun 14.

PMID:
23770109
48.

Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis.

Lands LC, Stanojevic S.

Cochrane Database Syst Rev. 2013 Jun 13;(6):CD001505. doi: 10.1002/14651858.CD001505.pub3. Review. Update in: Cochrane Database Syst Rev. 2016;4:CD001505.

PMID:
23765216
49.

Long-term multicentre randomised controlled study of high frequency chest wall oscillation versus positive expiratory pressure mask in cystic fibrosis.

McIlwaine MP, Alarie N, Davidson GF, Lands LC, Ratjen F, Milner R, Owen B, Agnew JL.

Thorax. 2013 Aug;68(8):746-51. doi: 10.1136/thoraxjnl-2012-202915. Epub 2013 Feb 13.

PMID:
23407019
50.

Pressurized whey protein can limit bacterial burden and protein oxidation in Pseudomonas aeruginosa lung infection.

Kishta OA, Iskandar M, Dauletbaev N, Kubow S, Lands LC.

Nutrition. 2013 Jun;29(6):918-24. doi: 10.1016/j.nut.2012.11.009. Epub 2013 Feb 8.

PMID:
23395602

Supplemental Content

Loading ...
Support Center